2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow ABT-414: new trials by email Literature Review of ABT-414 trials Research Report on ABT-414
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma Whole Brain Radiation, Temozolomide, ABT-414 - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Completed | AbbVie | 53 | 2015-08-24 | 2020-09-03 |
| Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas Depatuxizumab mafodotin, Temozolomide, Lomustine - Glioblastoma | Phase 2 | Completed | AbbVie | 266 | 2015-02-17 | 2020-05-22 |
Glioblastoma (2) · Brain Neoplasms (1) · Glioma (1) · Lymphoma, Follicular (1)
AbbVie (2)
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Ireland (1) · Italy (1) · Japan (1) · Mexico (1) · Netherlands (1) · Poland (1)
PMID 28039367, PMID 29077941, PMID 29982805, PMID 31747009, PMID 33601293, PMID 34609773
2014 (1)